Journal
CLEVELAND CLINIC JOURNAL OF MEDICINE
Volume 80, Issue 4, Pages 209-217Publisher
CLEVELAND CLINIC
DOI: 10.3949/ccjm.80gr.12006
Keywords
-
Categories
Funding
- Reata Pharmaceuticals
Ask authors/readers for more resources
Diabetic nephropathy is becoming increasingly common with the aging of our population and the obesity epidemic. The major ways to prevent or slow its progression are by reducing blood pressure, controlling blood sugar, and inhibiting the renin-angiotensin-aldosterone axis. New therapeutic agents are also being tried.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
